title: Focal accumulation of a radiopharmaceutical in the liver on technetium-99m gated blood pool and Apcitide scintigraphy leading to the diagnosis of superior vena cava obstruction.
abstract: Focal increased enhancement or radiopharmaceutical uptake in the liver has been associated with superior vena cava syndrome. This report describes the finding in a patient imaged with a relatively new agent, Tc-99m Apcitide. The collateral pathways responsible for the liver "hot spot" are reviewed, as is the role of Tc-99m Apcitide in deep venous thrombosis imaging.
authors.affiliation: Department of Radiology, Wilford Hall Medical Center, 2200 Bergquist Drive, Suite 1, Lackland Air Force Base, TX 78236-5300, USA.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Sherman
authors.forename: Robert S
authors.initials: RS
authors.lastname: Bridwell
mesh_terms: D001943:Breast Neoplasms / Q000150:complications / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging* / Q000378:metabolism; D008875:Middle Aged; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics*; D010456:Peptides, Cyclic; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D013479:Superior Vena Cava Syndrome / Q000000981:diagnostic imaging* / Q000209:etiology / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D015609:Organotechnetium Compounds; D010456:Peptides, Cyclic; D019275:Radiopharmaceuticals; C094919:technetium Tc 99m P280